BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat…
November 15, 2022 - 2 minutes
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat…